METHOD FOR PRODUCING 1,4-BENZOXAZINE COMPOUND

(19)

(11)

EP 2 883 870 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	23.01.2019 Bulletin 2019/04

(45)	Mention of the grant of the patent:
	24.10.2018 Bulletin 2018/43

(21)	Application number: 13828067.2

(22)	Date of filing: 08.08.2013

(51)

International Patent Classification (IPC):

C07D 265/36^(2006.01)
A61P 5/40^(2006.01)
A61P 9/00^(2006.01)
A61P 13/12^(2006.01)
C07B 61/00^(2006.01)

A61K 31/538^(2006.01)
A61P 5/42^(2006.01)
A61P 9/12^(2006.01)
A61P 43/00^(2006.01)

(86)	International application number:
	PCT/JP2013/071446

(87)	International publication number:
	WO 2014/024950 (13.02.2014 Gazette 2014/07)

(54)	METHOD FOR PRODUCING 1,4-BENZOXAZINE COMPOUND VERFAHREN ZUR HERSTELLUNG EINER 1,4-BENZOXAZIN-VERBINDUNG PROCÉDÉ DE FABRICATION D'UN COMPOSÉ 1,4-BENZOXAZINE

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)

Priority:

08.08.2012 JP 2012176217
18.01.2013 JP 2013007041

(43)	Date of publication of application:
	17.06.2015 Bulletin 2015/25

(60)	Divisional application:
	16178154.7 / 3112354

(73)	Proprietor: Mitsubishi Tanabe Pharma Corporation
	Osaka 541-8505 (JP)

(72)

Inventors:

OKABE, Tomoyuki
Osaka-shi, Osaka 541-8505 (JP)
HAMADA, Takeshi
Osaka-shi, Osaka 541-8505 (JP)
TOMIKAWA, Kaori
Osaka-shi, Osaka 541-8505 (JP)
OKAMOTO, Yukie
Osaka-shi, Osaka 541-8505 (JP)
IIJIMA, Toru
Osaka-shi, Osaka 541-8505 (JP)
AKATSUKA, Hidenori
Osaka-shi, Osaka 541-8505 (JP)
TOYAMA, Kenichi
Osaka-shi, Osaka 541-8505 (JP)
MORODA, Atsushi
Osaka-shi, Osaka 541-8505 (JP)
SUGIURA, Yoshihiro
Osaka-shi, Osaka 541-8505 (JP)

(74)	Representative: Hoffmann Eitle
	Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München 81925 München (DE)

(56)

References cited: :

WO-A1-2007/089034
JP-A- 2008 115 149

JP-A- 2006 505 575
JP-A- 2009 051 830

DAVID W. PIOTROWSKI: "Mineralocorticoid Receptor Antagonists for the Treatment of Hypertension and Diabetic Nephropathy", JOURNAL OF MEDICINAL CHEMISTRY, vol. 55, no. 18, 6 August 2012 (2012-08-06), pages 7957-7966, XP55213613, ISSN: 0022-2623, DOI: 10.1021/jm300806c
Bin Su ET AL: "Synthesis and Biological Evaluation of Selective Aromatase Expression Regulators in Breast Cancer Cells", Journal of Medicinal Chemistry, vol. 50, no. 7, 1 April 2007 (2007-04-01), pages 1635-1644, XP055000847, ISSN: 0022-2623, DOI: 10.1021/jm061133j

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).